4D Molecular Therapeutics (FDMT) Q2 2026 Earnings Report

528 Followers

FDMT Q2 2026 EPS Results

Actual EPS-$1.04

Consensus EPS-$1.02

Beat/MissMissed by -$0.02

One Year Ago EPS-$0.98

Actual Revenue$3.78M

Expected Revenue$3.62M

Beat/MissBeat by +$161.00K

YoY Revenue Growth+25106.67%

QuarterQ2 2026

Date08/13/2026

TimeAfter Close

Conference CallThursday, August 13, 2026

FDMT Upcoming Earnings

4D Molecular Therapeutics's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-1.05 / -	-1.01	―
Aug 13, 2026	2026 (Q2)	-1.02 / -1.04	-0.98	-6.12% (-0.06)
May 07, 2026	2026 (Q1)	-1.00 / -1.01	-0.86	-17.44% (-0.15)
Mar 18, 2026	2025 (Q4)	-0.53 / 0.43	-0.89	148.31% (+1.32)
Nov 10, 2025	2025 (Q3)	-0.98 / -1.01	-0.79	-27.85% (-0.22)
Aug 11, 2025	2025 (Q2)	-0.73 / -0.98	-0.63	-55.56% (-0.35)
May 08, 2025	2025 (Q1)	-0.87 / -0.86	-0.66	-30.30% (-0.20)
Feb 28, 2025	2024 (Q4)	-0.83 / -0.89	-0.69	-28.99% (-0.20)
Nov 13, 2024	2024 (Q3)	-0.68 / -0.79	-0.24	-229.17% (-0.55)
Aug 08, 2024	2024 (Q2)	-0.68 / -0.63	-0.77	18.18% (+0.14)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed